Neurogene Inc
NASDAQ:NGNE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neurogene Inc
NASDAQ:NGNE
|
US |
|
DC Infotech and Communication Ltd
NSE:DCI
|
IN |
|
K
|
Khemani Distributors & Marketing Ltd
BSE:539788
|
IN |
|
Warrego Energy Ltd
ASX:WGO
|
AU |
|
K
|
Kretto Syscon Ltd
BSE:531328
|
IN |
Balance Sheet
Balance Sheet Decomposition
Neurogene Inc
Neurogene Inc
Balance Sheet
Neurogene Inc
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
9
|
2
|
11
|
15
|
40
|
32
|
52
|
77
|
143
|
193
|
142
|
38
|
148
|
137
|
104
|
|
| Cash |
9
|
1
|
7
|
8
|
2
|
4
|
13
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
1
|
4
|
7
|
37
|
29
|
39
|
52
|
143
|
193
|
142
|
38
|
148
|
137
|
104
|
|
| Short-Term Investments |
0
|
0
|
3
|
24
|
35
|
71
|
56
|
0
|
0
|
0
|
0
|
58
|
49
|
176
|
165
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
3
|
2
|
|
| Total Current Assets |
9
|
2
|
15
|
39
|
75
|
103
|
109
|
77
|
144
|
195
|
144
|
99
|
200
|
316
|
272
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
3
|
14
|
17
|
16
|
21
|
18
|
15
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
3
|
14
|
17
|
16
|
21
|
18
|
15
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
3
|
8
|
11
|
14
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
2
|
38
|
50
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| Total Assets |
10
N/A
|
2
-76%
|
16
+568%
|
41
+165%
|
113
+174%
|
154
+36%
|
110
-29%
|
78
-30%
|
147
+89%
|
211
+43%
|
163
-22%
|
116
-29%
|
223
+92%
|
336
+51%
|
289
-14%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
2
|
7
|
6
|
1
|
2
|
1
|
1
|
0
|
3
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
2
|
4
|
3
|
3
|
5
|
4
|
3
|
7
|
8
|
10
|
20
|
12
|
13
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
1
|
0
|
3
|
5
|
5
|
10
|
11
|
5
|
5
|
8
|
9
|
11
|
23
|
15
|
16
|
|
| Long-Term Debt |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
12
|
10
|
14
|
10
|
7
|
|
| Total Liabilities |
1
N/A
|
1
+13%
|
7
+410%
|
5
-30%
|
5
-7%
|
10
+97%
|
11
+18%
|
5
-57%
|
5
+8%
|
19
+262%
|
20
+6%
|
22
+6%
|
37
+69%
|
25
-31%
|
24
-6%
|
|
| Equity | ||||||||||||||||
| Common Stock |
48
|
53
|
74
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
40
|
52
|
66
|
89
|
111
|
148
|
199
|
230
|
300
|
333
|
393
|
451
|
187
|
262
|
353
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
126
|
220
|
293
|
297
|
303
|
441
|
524
|
536
|
545
|
373
|
573
|
618
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
1
-90%
|
8
+834%
|
36
+343%
|
108
+200%
|
145
+33%
|
99
-32%
|
73
-27%
|
142
+95%
|
191
+35%
|
143
-25%
|
94
-34%
|
186
+97%
|
310
+67%
|
265
-15%
|
|
| Total Liabilities & Equity |
10
N/A
|
2
-76%
|
16
+568%
|
41
+165%
|
113
+174%
|
154
+36%
|
110
-29%
|
78
-30%
|
147
+89%
|
211
+43%
|
163
-22%
|
116
-29%
|
223
+92%
|
336
+51%
|
289
-14%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
13
|
15
|
15
|
|